Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Randomised double blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 유대현 | - |
| dc.date.accessioned | 2021-08-03T02:26:24Z | - |
| dc.date.available | 2021-08-03T02:26:24Z | - |
| dc.date.issued | 2017-06-17 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/32107 | - |
| dc.title | Randomised double blind study shows comparable long-term efficacy and safety between rituximab biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: 48-week results | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | EULAR 2017 | - |
| dc.citation.conferencePlace | Madrid, Spain | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.